We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
+5.51%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$236M
AUM Growth
-$73.4M
Cap. Flow
-$88.9M
Cap. Flow %
-37.61%
Top 10 Hldgs %
99.67%
Holding
14
New
2
Increased
–
Reduced
6
Closed
2

Top Buys

Rank Stock Value
1
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$11.2M
2
SVRA icon
Savara
SVRA
+$411K

Top Sells

Rank Stock Value
1
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$32.6M
2
PETX
Aratana Therapeutics, Inc.
PETX
+$31.3M
3
EPZM
Epizyme, Inc
EPZM
+$14.1M
4
KBIO
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
+$11.6M
5
PCRX icon
Pacira BioSciences
PCRX
+$4.15M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EPZM
1
DELISTED
Epizyme, Inc
EPZM
$55M 23.26%
2,413,819
-466,666
-16% -$14.1M
PETX
2
DELISTED
Aratana Therapeutics, Inc.
PETX
$51.7M 21.9%
2,788,165
-1,562,883
-36% -$31.3M
MGNX icon
3
MacroGenics
MGNX
$263M
$49.6M 20.98%
1,780,955
– –
PTLA
4
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$31.6M 13.38%
1,220,672
-1,220,672
-50% -$32.6M
EIGR
5
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$12.7M 5.38%
+2,371
New +$11.2M
ALT icon
6
Altimmune
ALT
$605M
$11.6M 4.92%
21,159
– –
HSTO
7
DELISTED
Histogen Inc. Common Stock
HSTO
$9.7M 4.11%
5,960
– –
VSTM icon
8
Verastem
VSTM
$654M
$8.81M 3.73%
68,057
-18,053
-21% -$2.88M
PCRX icon
9
Pacira BioSciences
PCRX
$1.03B
$2.73M 1.16%
39,025
-60,975
-61% -$4.15M
ETRM
10
DELISTED
EnteroMedics Inc.
ETRM
$2.03M 0.86%
1,060
-530
-33% -$1.25M
SGMO
11
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$407K 0.17%
22,487
– –
SVRA icon
12
Savara
SVRA
$1.08B
$362K 0.15%
+7,498
New +$411K
AVEO
13
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
– –
-137,212
Closed -$2.51M
KBIO
14
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
– –
-329,116
Closed -$11.6M

Similar funds

WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

MPM Asset Management's Q1 2014 Portfolio in Review

As of Q1 2014, MPM Asset Management held 14 positions worth $236M, down 24% from $310M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

MPM Asset Management withdrew a net $88.9M in Q1 2014, closing 2 positions and reducing 6 holdings. Its most notable exit was KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE), an estimated $11.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 96% a quarter earlier.

Against the trend, MPM Asset Management opened a new position in Eiger BioPharmaceuticals, Inc. worth $12.7M.

  • MPM Asset Management's largest Q1 2014 buy was Eiger BioPharmaceuticals, Inc.: 2,371 shares worth $12.7M.
  • MPM Asset Management's biggest Q1 2014 reduction was Portola Pharmaceuticals, Inc., cutting an estimated $32.6M.
  • MPM Asset Management fully exited KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q1 2014, selling an estimated $11.6M.
  • MPM Asset Management's ten largest holdings make up 100% of its $236M portfolio in Q1 2014.
  • MPM Asset Management opened 2 new positions and closed 2 in Q1 2014.
  • MPM Asset Management's portfolio value fell 24% quarter-over-quarter to $236M.

Based on MPM Asset Management's 13F filing for Q1 2014, filed 8 May 2014.